Skip to main content

Second series of cycles of 177Lu-PSMA-617 radioligand therapy for patients with lymph node metastatic prostate cancer. A report of two cases

8 stars
von Eyben
Finn
Head office
Center for Tobacco Control Research
Odense
Danmark
Show all authors
Finn

Tabs

Speciality: 
Other
Keywords: 
177Lutetium, PSMA, radioligand therapy, radionuclied treatment